Agile Therapeutics Provides Clinical Update on Twirla and Status of Pipeline…
<!-- Name:DistributionId Value:8740354 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Agile Therapeutics
Agile Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment…
PRINCETON, N.J., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced that Chairman and Chief Executive Officer Al Altomari…
Agile Therapeutics to Participate in Maxim Group’s Upcoming Women’s Health Panel
PRINCETON, N.J., July 08, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and CEO Al Altomari will be…
Agile Therapeutics Announces Closing of $24 Million Upsized Public Offering
PRINCETON, N.J., July 06, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the…
Agile Therapeutics Announces Pricing of $24 Million Upsized Public Offering
PRINCETON, N.J., July 01, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) ("Agile Therapeutics" or the "Company"), a women's healthcare company, today announced the…
Agile Therapeutics Announces First Quarter 2022 Prescription Data for Twirla®
29% increase in Twirla cycles27% increase in total prescriptions (TRx) of Twirla PRINCETON, N.J., April 14, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's…
Agile Therapeutics® Announces First Twirla® Commercial Targeting Gen Z
Partners with Award-Winning Director Maya Albanese “Patch and Play” introduces the features of the Twirla (levonorgestrel and ethinyl estradiol) transdermal system, while highlighting the…
Agile Therapeutics to Participate in Upcoming March Investor Events
PRINCETON, N.J., March 11, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Chairman and Chief Executive Officer Al…
Agile Therapeutics to Present at the Biotech Showcase and H.C. Wainwright BioConnect…
PRINCETON, N.J., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced Chairman and Chief Executive Officer Al Altomari …
Agile Therapeutics Announces Pricing of $22,666,650 Underwritten Public Offering of…
PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced the pricing of its underwritten public offering…